Presence of staphylococcal exfoliative toxin A in sera of patients with atopic dermatitis

Clinical and Experimental Allergy

Volumn 34, Issue 6, 2004, Pages 984-993

  Yagi, S ^a,d   Wakaki, N ^a   Ikeda, N ^a   Takagi, Y ^b   Uchida, H ^c   Kato, Y ^a   Minamino, M ^a  

^a Club Cosmetics Co Ltd   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^d Club Cosmetics Co Ltd   (Japan)

Author keywords

Atopic dermatitis; Exfoliative toxin A; Serum; Specific IgE; Specific IgG; Staphylococcal enterotoxin; Staphylococcus aureus

Indexed keywords

BACTERIAL TOXIN; EXFOLIATIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; STAPHYLOCOCCAL EXFOLIATIVE TOXIN A; STAPHYLOCOCCUS ENTEROTOXIN A; STAPHYLOCOCCUS ENTEROTOXIN B; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; ATOPIC DERMATITIS; BLOOD ANALYSIS; BLOOD LEVEL; CHILD; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; BACTERIAL TOXINS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXFOLIATINS; FEMALE; HEMOLYSIN PROTEINS; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MALE; SKIN; SPHINGOMYELIN PHOSPHODIESTERASE; STAPHYLOCOCCAL INFECTIONS; STATISTICS, NONPARAMETRIC;

EID: 3042675151     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.1687.x     Document Type: Article

References (41)

1. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994; 102:128-37.
2. Svejgaard E. The role of microorganisms in atopic dermatitis. Sem Dermatol 1990; 9:255-61.
3. Ring J, Abeck D, Neuber K. Atopic eczema: role of microorganisms on the skin surface. Allergy 1992; 47:265-9.
4. Hoeger PH, Lentz W, Boutonier A, Fournier JM. Staphylococcal skin colonization in children with atopic dermatitis: prevalence, persistence, and transmission of toxigenic and nontoxigenic strains. J Infect Dis 1992; 165:1064-8.
5. Williams JV, Vowels B, Honig P, Leyden JJ. Staphylococcus aureus isolation from the lesions, the hands, and anterior nares of patients with atopic dermatitis. J Emerg Med 1999; 17:207-11.
6. Nishijina S, Namura S, Higashida T, Kawai S. Staphylococcus aureus in the anterior nares and subungual spaces of the hands in atopic dermatitis. J Intern Med Res 1997; 25:155-8.
7. Zollner TM, Wichelhaus TA, Hartung A et al. Colonization with superantigen-producing Staphylococcus aureus is associated with increased severity of atopic dermatitis. Clin Exp Allergy 2000; 30:994-1000.
8. Bunikowski R, Mielke ME, Skarabis H et al. Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis. J Allergy Clin Immunol 2000; 105:814-9.
9. Leung DY, Harbeck R, Bina P et al. Presence of IgE antibodies to Staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J Clin Invest 1993; 92:1374-80.
10. Akiyama H, Toi Y, Kanzaki H, Tada J, Arata J. Prevalence of producers of enterotoxins and toxic shock syndrome toxin-1 among Staphylococcus aureus strains isolated from atopic dermatitis lesions. Arch Dermatol Res 1996; 288:418-20.
11. Tada J, Toi Y, Akiyama H, Arata J, Kato H. Presence of specific IgE antibodies to staphylococcal enterotoxins in patients with atopic dermatitis. Eur J Dermatol 1996; 6:552-4.
12. Nomura I, Tanaka K, Tomita H et al. Evaluation of the staphylococcal exotoxins and their specific IgE in childhood atopic dermatitis. J Allergy Clin Immunol 1999; 104:441-6.
13. Leung DYM. The immunologic basis of atopic dermatitis. Clin Rev Allergy 1993; 11:447-68.
14. Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990; 248:705-11.
15. Tokura Y, Yagi J, O'Malley M et al. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class Ii-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines. J Invest Dermatol 1994; 102:31-8.
16. Strange P, Skov L, Baadsgaard O. Interferon gamma-treated keratinocytes activate T-cells in the presence of superantigens: involvement of major histocompatibility complex class II molecules. J Invest Dermatol 1994; 102:150-4.
17. Bos JD, Wierenga EA, Smitt JHS, Heijden FI, Kapsenberg ML. Immune dysregulation in atopic eczema. Arch Dermatol 1992; 128:1509-12.
18. Breuer K, Wittmann M, Bosche B, Kapp A, Werfel T. Severe atopic dermatitis is associated with sensitization to staphylococcal enterotoxin B (SEB). Allergy 2000; 55:551-5.
19. Lin YT, Yang YH, Hwang YW et al. Comparison of serum specific IgE antibodies to staphylococcal enterotoxins between atopic children with and without atopic dermatitis. Allergy 2000; 55: 641-6.
20. Halbert AR, Weston WL, Morelli JG. Atopic dermatitis: is it an allergic disease? J Am Acad Dermatol 1995; 33:1008-18.
21. Peterson RDA, Page ARP, Good RA. Wheal and erythema allergy in patients with agammaglobulinaemia. J Allergy 1962; 33:406-11.
22. Campbell DE, Kemp AS. Production of antibodies to staphylococcal superantigens in atopic dermatitis. Arch Dis Child 1998; 79:400-4.
23. Sowden JM, Berth JJ, Ross JS et al. Double-blind, controlled crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 1991; 338:137-40.
24. Strange P, Skov L, Lisby S, Nielsen PL, Baadsgard O. Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Arch Dermatol 1996; 132:27-33.
25. Bunikowski R, Mielke M, Skarabis H et al. Prevalence and role of serum IgE to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis. J Allergy Clin Immunol 1999; 103:119-24.
26. Morishita Y, Tada J, Sato A et al. Possible influences of Staphylococcus aureus on atopic dermatitis - the colonizing features and the effects of staphylococcal enterotoxins. Clin Exp Allergy 1999; 29:1110-7.
27. Capoluongo E, Giglio AA, Lavieri MM et al. Genotypic and phenotypic characterization of Staphylococcus aureus strains isolated in subjects with atopic dermatitis. Higher prevalence of exfoliative B toxin production in lesional strains and correlation between the markers of disease intensity and colonization density. J Dermatol Sci 2001; 26:145-55.
28. Capoluongo E, Giglio A, Belardi M et al. Association between lesional S. aureus strains from patients with impetigo and exfoliative toxin production. No association with SmaI PFGE patterns. New Microbiol 2000; 23:21-7.
29. Kanzaki H, Ueda M, Morishita Y, Akiyama H, Arata J, Kanzaki S. Producibility of exfoliative toxin and staphylococcus coagulase types of Staphylococcus aureus strains isolated from skin infections and atopic dermatitis. Dermatology 1997; 195:6-9.
30. Opal SM, Johnson-Winegar AD, Cross AS. Staphylococcal scalded skin syndrome in two immunocompetent adults caused by exfoliative B-producing Staphylococcus aureus. J Clin Microbiol 1988; 26:1283-6.
31. Murono K, Fujita K, Yoshikawa H. Detection of Staphylococcal exfoliative toxin by slide latex agglutination. J Clin Microbiol 1988; 26:271-4.
32. Sarai Y, Nakahara H, Ishikawa T, Kondo I, Futaki S, Hirayama K. A bacteriological study on children with Staphylococcal toxic epidermal necrolysis in Japan. Dermatologica 1977; 154:161-7.
33. Plano LR, Adkins B, Woischnik M, Ewing R, Collins CM. Toxin levels in serum correlate with the development of Staphylococcal scalded skin syndrome in a murin model. Infect Immun 2001; 69:5193-7.
34. Merlsh ME, Glasgow A. The Staphylococcal scalded-skin syndrome. N Engl J Med 1970; 282:1114-9.
35. Ladhani S, Joannou CL, Lochrie DP, Evans RW, Poston SM. Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome. Clin Microbiol Rev 1999; 12:224-42.
36. Ladihani S, Robbie S, Garratt RC, Chapple DS, Joannou CL, Evans RW. Development and evaluation of detection system for staphylococcal exfoliative toxin A responsible for scalded-skin syndrome. J Clin Microbiol 2001; 39:2050-4.
37. Tarkhanova IA, Rudenskii AI, Sycheva IM, Kulberg AI. Interrelationship between the structure of IgG and its Fc-fragment and their ability to react with protein A of Staphylococcus aureus. Biull Eksp Biol Med 1980; 89:318-20.
38. Machida K, Sakurai S, Rondo I, Ikawa S. Relationship between susceptibility and immune response to staphylococcal exfoliative toxin A in mammalian-species. Microbiol Immunol 1988; 32:1079-84.
39. Machida K. Immunological investigations on pathogenesis of staphylococcal scalded skin syndrome. Rinsho Byori 1995; 43:547-56.
40. Gabrielsen T, Brandtzaeg P. Enzyme-linked immunosorbent assay (ELISA) for isotype-specific quantitation of antibodies to Staphylococcus aureus in patients with atopic dermatitis. Acta Derm Venereol (Stockh) 1985; 114:61-6.
41. Monday SR, Vath GM, Ferens WA et al. Unique superantigen activity of staphylococcal exfoliative toxins. J Immunol 1999; 162:4550-9.